Narcan Goes OTC in the US
The US Food and Drug Administration (FDA) has approved over-the-counter (OTC) sales of Narcan (naloxone), a drug used to immediately treat an opioid overdose. The drug could previously be prescribed and sold at many pharmacies, but the OTC designation should expand the reach of the drug to more pharmacies and people who may use the drug on others.
Opioid Overdose Drug Narcan Gets FDA Approval to Go OTC
The US Food and Drug Administration (FDA) voted unanimously yesterday, February 15th, to approve the over-the-counter sale of Narcan (naloxone), a drug that can interrupt an otherwise lethal opioid overdose immediately. The move would make the non-prescription drug much more accessible to patients who otherwise would face varying barriers to purchase.
Bipartisan Letter Expresses Concerns About Naloxone Shortages to Merrick Garland
Congressional members of both parties have penned a letter to Attorney General Merrick Garland regarding their concerns over recent settlements [...]
